A recent study indicates that patients who come off popular weight-loss injections like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who stop traditional diet and exercise programs.
Findings released in a leading health publication demonstrates that while obese individuals often shed about a fifth of their total mass while on the medication, the weight comes back at an average rate of 0.8 kg per month after stopping.
"People using these medications must be cognizant of the risk of quick weight regain when the medication ends," stated lead investigator Dr. Susan Jebb.
That rate of regain suggests a return to pre-treatment weight within about 18 months.
Comparing Therapies
The research, which examined 37 of studies involving thousands of participants, contrasted the results of these new drugs with other pills.
Scientists point out that individuals who shed pounds through diet and exercise usually see a less rapid creep back—around 100 grams monthly—after stopping.
Explaining the Fast Regain
Nutrition scientists suggest the way of the jabs accounts for the heightened regain.
GLP-1 drugs mimic a natural hormone called GLP-1, which controls hunger.
"Sustained high doses of GLP-1 concentrations several times higher than normal could lead to the body to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.
"Stopping of this medication leads to appetite is uncontrolled, making overeating a significant risk."
A Chronic Issue?
Health authorities recommend the jabs for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Many experts contend that, due to the high risk of weight regain, the therapy should be considered life-long.
This view is reinforced by drug manufacturers, who say that the results "emphasize the persistent nature of excess weight," comparing it to managing conditions like hypertension.
Patient Testimonies
Users who have discontinued the medication explain a intense resurgence of cravings.
"It felt as if a switch that goes on and you're instantly starving," said a patient.
This difficulty is worsened if patients have not developed lasting lifestyle or habit changes during treatment.
Growing Use
Recent estimates suggest that millions of people in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.
- Use is greater among women compared to men.
- The 40s and 50s age group shows the highest level of interest.
- Many access the drugs through private healthcare rather than public health services.
Ultimately, clinicians emphasize that while the jabs are potent tools for weight loss, they are not a permanent cure and long-term success likely depends on integrated behavioural support.